- NSE
- GLAXO
- BSE
- 500660
- ISIN
- INE159A01016
GLAXOSMITHKLINE PHARMA LT
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹2,524.80
+₹24.60 (+0.98%)
NSE close ·
GLAXOSMITHKLINE PHARMA LT closed at ₹2,524.80 on 6 Nov 2026, up 0.98% on the day, and is down 3.10% over the past year.
Price history
Between 6 Nov 2025 and 6 Nov 2026, the closing price ranged from ₹2,103.20 to ₹3,106.40.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹42,772 Cr
- Industry P/E
- 35.1
- Dividend yield
- 2.26%
Market cap and yield at the 6 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹982 Cr | ₹237 Cr | — | ₹14.00 |
Armor risk check
GLAXOSMITHKLINE PHARMA LT moves about 1.8× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is GLAXOSMITHKLINE PHARMA LT's share price today?
GLAXOSMITHKLINE PHARMA LT (NSE: GLAXO) closed at ₹2,524.80 on 6 Nov 2026, up 0.98% from the previous close of ₹2,500.20. It traded between ₹2,489.30 and ₹2,544.80 that day.
What are GLAXOSMITHKLINE PHARMA LT's 52-week high and low?
Over the last 52 weeks GLAXOSMITHKLINE PHARMA LT traded between ₹2,088.10 and ₹3,120.70, adjusted for splits and bonuses.
What are GLAXOSMITHKLINE PHARMA LT's NSE symbol, BSE code and ISIN?
GLAXOSMITHKLINE PHARMA LT has NSE symbol GLAXO, BSE code 500660, ISIN INE159A01016.
How has GLAXOSMITHKLINE PHARMA LT performed over 1, 3 and 5 years?
GLAXOSMITHKLINE PHARMA LT's share price return: 1Y −3.10%, 3Y +20.83% a year, 5Y +9.00% a year. Dividends are not included.
Does GLAXOSMITHKLINE PHARMA LT pay a dividend?
Yes. GLAXOSMITHKLINE PHARMA LT's latest dividend went ex on 29 May 2026: Final · ₹57.00 per share. Dividends over the past year come to a yield of 2.26% at the latest close.
What is GLAXOSMITHKLINE PHARMA LT's market cap?
GLAXOSMITHKLINE PHARMA LT's market cap is ₹42,772 Cr at the close on 6 Nov 2026.
Which sector is GLAXOSMITHKLINE PHARMA LT in?
GLAXOSMITHKLINE PHARMA LT is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how GLAXOSMITHKLINE PHARMA LT fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app